Logotype for Mold-Tek Packaging Limited

Mold-Tek Packaging (533080) Q1 26/27 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Mold-Tek Packaging Limited

Q1 26/27 earnings summary

10 Sep, 2026

Executive summary

  • Achieved record quarterly turnover exceeding ₹300 crore, with YoY revenue growth of 24.90% and sequential growth of 26.32%, driven by strong demand in pharma, food, FMCG, and paints.

  • EBITDA per kg reached an all-time high of ₹46.68, up from ₹41.64 YoY, reflecting operational efficiencies, product mix improvements, and Hyderabad unit consolidation.

  • PAT increased to ₹25.57 crore, up 14.19% YoY and 23.89% sequentially, with EPS rising to 7.70.

  • Sales volume grew 6.25% YoY and 5.82% sequentially, led by pharma and FMCG.

  • Consolidation of Hyderabad units and automation initiatives significantly reduced overheads and improved margins.

Financial highlights

  • Q1 FY27 revenue from operations was ₹300.45 crore, up from ₹240.56 crore in Q1 FY26 (24.90% growth).

  • EBITDA for Q1 FY27 was ₹56.43 crore, up from ₹47.38 crore YoY (19.11% growth).

  • PAT for Q1 FY27 was ₹25.57 crore, up from ₹22.40 crore YoY (14.19% growth).

  • EBITDA margin per kg improved to ₹46.68, up ₹6 YoY.

  • Finance costs increased by 20% quarter-on-quarter and 38% YoY, mainly due to higher working capital needs.

Outlook and guidance

  • Management targets 10–12% volume growth for FY2027, with double-digit growth in paints and strong momentum in food, FMCG, and pharma.

  • EBITDA per kg is projected to remain above ₹44–₹45 for the year, surpassing earlier guidance.

  • Expansion into new geographies and high-margin areas like ophthalmic packs, medical devices, and semiconductor packaging is planned.

  • Continued focus on R&D, automation, and innovation to drive value and resilience.

  • Paint segment's revenue share expected to decline as food, FMCG, and pharma outpace paint growth.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more